U.S. Gene Therapy in CNS Disorder Market Forecast 2025–2035: Trends and Growth Insights
The Gene Therapy in CNS Disorder Market is on track to reach USD 13.86 billion
Gene Therapy in CNS Disorder Market Share 2023 to 2033 | By Novartis AG, Bluebird Bio, Biogen, Pfizer
According to projections, the global market for Gene Therapy in CNS Disorders will reach a